Summary: Worldline

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to MSCI.

Highlights: Worldline

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.85 for the current period. Therefore, the company is undervalued.
  • The company appears to be poorly valued given its net asset value.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses: Worldline

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company sustains low margins.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The group usually releases earnings worse than estimated.

Ratings Chart: Worldline

Source: Surperformance

ESG chart: Worldline

Source: MSCI

Add to a list
Fundamentals Valuation Revisions of Fundamental Estimates Capi.($)
2.25B
162B
50.57B
49.38B
44.91B
23.92B
23.36B
14.57B
8.98B
Average 42.22B
Weighted average by Cap.
See all sector ratings
Investor
Trader
ESG MSCI
AA

Financials

Sales growth
EPS Growth
Profitability
Net margin
Financial Health

Valuation

P/E ratio
EV/REVENUE
EV/EBITDA
PBR
Yield
-

Revisions

1 year Revenue revision
4 months Revenue revision
1 months Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analysts' recommendations
4m Revision of opinion
Potential Price Target
4m Target Price Revision
12m Target Price Revision

Business Predictability

Earnings quality
Analyst Coverag
Divergence of analysts' recommendations
Divergence of Target Price
Divergence of analysts' opinions

ESG

Environment
Social
Governance
Controversy
ESG: Ethical controversies
ESG: Human rights controversies
ESG: Tax subsidies controversies
Sharia compliant
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes